Look Kirk bought ONCY
June 1, 2026 · Form 4 insider transaction
Look Kirk bought 260,000 shares of Oncolytics Biotech Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
260,000
Price
$0.00
Total value
N/A
InsiderLook Kirk
Role—
SecurityStock Option
Transaction codeA: Grant or award
Transaction dateJune 1, 2026
Filing dateJune 3, 2026
Shares owned after260,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The exercise price is equal to the closing price of the Issuer's common stock on the Nasdaq Capital Market on the date of grant, June 1, 2026.; The stock option vests in three equal annual installments with the first tranche vesting on June 1, 2027, subject to the Reporting Person's continued service or employment, as applicable, on each such vesting date.